Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Miami
Age
4–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
all patients with a diagnosis of phenylketonuria
patients who are over the age of 4 years,
patients with a fasting blood phenylalanine ≥600µmol/l
You may not be if
female patients who are pregnant or attempting to become pregnant
children under four years of age
Concurrent disease of condition that would interfere with study participation or safety such as history of neurological compromise or major medical, psychiatric or learning disorder unrelated to PKU
Any condition that, in the view of the Investigators, places subject at high risk of poor treatment compliance or of not completing the study
Use of L-Dopa, methotrexate, or other drugs that may inhibit folate metabolism
Clareo Health | Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
